Profile
VAXX NVO VRTX REGN SGEN ARGX
Company Name Vaxxinity, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $6.34M $372.46B $106.01B $74.66B $43.15B $40.18B
Employees 0.06K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Ms. Mei Mei Hu J.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
Trading
VAXX NVO VRTX REGN SGEN ARGX
Last Close $0.0005 $81.18 $411.66 $690.87 $228.74 $665.6
High 52 $0.86 $146.91 $516.74 $1201.76 $228.74 $670.4
Low 52 - $81.18 $392.81 $690.87 $228.74 $356.01
Price vs. 52 Week High -99.94 % -44.74 % -20.34 % -42.51 % 0 % -0.72 %
Price vs. 52 Week Low 0 % 0 % 4.8 % 0 % 0 % 86.96 %
Total Return
VAXX NVO VRTX REGN SGEN ARGX
1 Month Return 400 % -24.1 % -11.23 % -5.53 % 0 % 9.62 %
3 Month Return -87.5 % -31.09 % -15 % -32.04 % 0 % 22.19 %
6 Month Return -99.87 % -42.58 % -16.13 % -36.16 % 0 % 44.09 %
9 Month Return -99.89 % -34.48 % 3.6 % -23.11 % 0 % 76.9 %
YTD Return -90 % -5.63 % 2.22 % -3.01 % 0 % 8.23 %
1 Year Return -99.94 % -24.24 % -5.02 % -25.97 % 0 % 78.13 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VAXX NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.66 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -46.26 % 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
VAXX NVO VRTX REGN SGEN ARGX
Asset Growth -58.35 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth -32.66 % 32.32 % 9.64 % 6.49 % 22.93 % 190.7 %
Revenue Growth - 31.26 % 10.51 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year -100 % 90.03 % 60.36 % 55.67 % 91.56 % 2071.96 %
Revenue 5 Year - 123.63 % 219.55 % 110.3 % 215.48 % 3041.46 %
Revenue 10 Year - 65.69 % 610.45 % 549.62 % 494.04 % 9009.53 %
EBIT Growth 23.29 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Net Income Growth 99.92 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share -59.59 % 106.26 % 34.59 % 13.48 % -763.59 % 64.01 %
Net Income 5 Yeari Growth Per Share -297.07 % 133.27 % 70.33 % 74.02 % -276.93 % -143.65 %
Net Income 10 Yeari Growth Per Share -297.07 % 98.1 % 809.6 % 871.12 % -624.16 % -857 %
Operating Income Growth 23.29 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) -2.34 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG -167285.14 % 117.73 % 9.63 % 76.95 % -147.99 % 21.71 %
Operating 5 Year CFG -462682.73 % 162.84 % 174.78 % 125.17 % -195.86 % -329.63 %
Operating 10 Year CFG -462682.73 % 150.28 % 6084.35 % 713.56 % -2622.09 % -1280.2 %
EPS Growth 25 % 51.88 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth 25 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share 21368.69 % 28.67 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share 15318.42 % 74.77 % 104.06 % 137.56 % 33.72 % 93.75 %
Share Holder 5 Year Equity Growth Per Share 27509.9 % 121.34 % 291.14 % 219.1 % 220.81 % 318.81 %
Share Holder 10 Year Equity Growth Per Share 27509.9 % 49.24 % 1030.79 % 1286.9 % 691.19 % 3654.06 %
Dividend Per Share Growth - 26.56 % - - - -
Dividend 3 Year Growth Per Share - 63.98 % - - - -
Dividend 5 Year Growth Per Share - 79.57 % - - - -
Dividend 10 Year Growth Per Share - 94.94 % - - - -
Debt Growth 4.25 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth -0.43 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
VAXX NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM - 84.66 % 86.1 % 84.42 % 72.37 % 86.82 %
Return on Assets TTM -55.37 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM -132.23 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM -93.97 % 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 100 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 97.78 % 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM - 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM -165.01 % 207.5 % -49.48 % 157.08 % -185.98 % -428.57 %
Receivables Turnover TTM - 3.89 6.06 2.27 1.98 3.45
Payables Turnover TTM 0.63 1.72 3.73 4.34 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.71 0.65 0.91
Fixed Asset Turnover TTM - 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM - 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM -0.2 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM -0.2 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 24.07 % 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM - 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.16 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM -165.01 % 207.5 % -49.48 % 157.08 % -185.98 % -428.57 %
Price To Free Cash Flows Ratio TTM -0.25 40.13 -91.09 22.11 -141.85 -190.24
Price To Operating Cash Flows Ratio TTM - 22.42 -126.05 17.58 -203.89 -274.79
Price Cash Flow Ratio TTM - 22.42 -126.05 17.58 -203.89 -274.79
Income Statement (TTM)
VAXX NVO VRTX REGN SGEN ARGX
Revenue $0B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $-0B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 0% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $-0B $113.33B $4.61B $4.69B $-0.62B $-0.22B
Net Income $-0B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -0.45 9.31 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
VAXX NVO VRTX REGN SGEN ARGX
Long Term Debt $0.01B $20.53B $0.72B $2.7B $0.04B $0.02B
Total Liabilities $0.03B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.01B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0.03B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0.02B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0.04B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
VAXX NVO VRTX REGN SGEN ARGX
Net Income $-0.06B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.995
ABCL AbCellera Biologics Inc. 2.77
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.09
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.56
ABPWW 0.0652
ABSI Absci Corporation 2.71
ABUS Arbutus Biopharma Corporation 3.18
ABVC ABVC BioPharma, Inc. 0.5157
ABVX Abivax SA American Depositary Shares 6.15
ACAD ACADIA Pharmaceuticals Inc. 16.9
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9092
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.17
ACHV Achieve Life Sciences, Inc. 3.15
ACIU AC Immune SA 2.61
ACLX Arcellx, Inc. 64.65
ACRV Acrivon Therapeutics, Inc. Common Stock 5.56
ETFs With Exposure to VAXX
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.0002 219.72
VTI Vanguard Total Stock Market Index Fund 0 288.42
IWO iShares Russell 2000 Growth ETF 0.00039 286.7
VXF Vanguard Extended Market Index Fund 0 191.49
HDG ProShares Hedge Replication ETF 0.0000307266 49.297
UWM ProShares Ultra Russell2000 0.0000698263 41.32
IWC iShares Micro-Cap ETF 0.00126 125.17
URTY ProShares UltraPro Russell2000 0.0000456626 48.09
VTWG Vanguard Russell 2000 Growth Index Fund 0 209.22
VTWO Vanguard Russell 2000 Index Fund 0 88.88
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 98.67
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 98.65
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 48.17
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 48.16
VBINX Vanguard Balanced Index Fund Investor Shares 0 48.16
VALT ETFMG Sit Ultra Short ETF 0.54 48.52
RYLD Global X Russell 2000 Covered Call ETF 0 16.4
GERM ETFMG Treatments, Testing and Advancements ETF 0.01 19.1577
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.55 1.75
VTSAX Vanguard Total Stock Market Index Fund 0 140.41
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 145.27
VITSX Vanguard Total Stock Market Index Fund 0 140.43
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000126388 98.66
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 145.28
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.000212343 35.55
VEMPX Vanguard Extended Market Index InstlPlus 0 358.5
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 263.43
Unlock